Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3709365 A
Publication typeGrant
Publication dateJan 9, 1973
Filing dateJun 1, 1970
Priority dateJun 1, 1970
Publication numberUS 3709365 A, US 3709365A, US-A-3709365, US3709365 A, US3709365A
InventorsT Czaplinski, T Haney
Original AssigneeSquibb & Sons Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Disposable pharmaceutical sterile closures
US 3709365 A
Abstract
Disclosed herein is a disposable sealed sterile closure for use primarily in radiopharmaceutical preparations. The stopper is of the type that can be pierced by a hypodermic needle to aseptically remove sterile, pyrogen-free material from a vial or generator.
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

UNITED STATESPATENTS Weyand et al ..2l0/446 x United States Patent 1191 1111 3,709,365 Czaplinski et al. 14 1 Jan. 9, 1973 I 54] DISPOSABLE PHARMACEUTICAL 3,392,726 7/1968 Pochyla 6161.. .;128/272 STERILE CLOSURES 2,127,203 8/1938 Brand ..l28/272 1 1 a 2,191,447 2/1940 Beardsley ..l28/272 UX [75] Inventors: Thomas V. Czaplinski, North Brunswick; Thomas A, H FOREIGN PATENTS OR APPLICATIONS East Brunswick both 692,598 8/1964 Canada ..210/233 [73] Asslgnee: t' & Sons New Primary Examiner-Reuben Friedman AssistantExaminer-Frederick F. Calvetti [22] Filed: June 1, 1970 Attorney-Lawrence S. Levinson, Merle J. Smith, v pp No: 42,354 Donald J. Perrella and Burton Rodney [57] ABSTRACT 310/233 210/446 210/451 Disclosed herein is a disposable sealed sterile closure 7 2 for use primarily in radiopharmaceutical preparations. [51] Int. Cl. ..B01d 35/00 The'stopper is of the type that can be pierced by a 58 Field 61 Search ..210/233, 446, 450, 451, 453, hypodermi nee l to aseptically remove r 210 455; 123 272 214 222 139 541 pyrogen-free material from a vial or generator.

4 Claims, 2 Drawing Figures [56] References Cited Pmrzmmm 9 191a 3.709.365

INVENTOR'SI THOMAS v. CZAPL/NSKI 2 B" THOMAS A. HANEY ATTORNEY DISPOSABLE PHARMACEUTICAL STERILE CLOSURES PRIOR ART Within the-past two decades the use of radiopharmaceuticals have gained wide acceptance by radiologists as aids in diagnosing various anatomical conditions. Various radioneuclides have become valuable diagnostic tools to the practicing physician to locate tumors and check the functioning body organs, such as the liver, kidneys, pancreatic tissue, and so forth. One of the primary sources of radioisotopes is delivered by a system commonly referred to as a radioisotope generator. In its operation a parent radioisotope is placed on a support and allowed to decay. The decayed product (daughter isotope) is then milked to yield the desired radioisotope. The daughter radioisotope is then utilized as a tracer and depending on the isotope utilized or the composition tagged with the daughter isotope, it will localize in various areas of the body. The bodyis then scanned with a suitable apparatus for detecting radiation, such as a scintillation spectrometer, to detect any abnormal localization of the daughter isotope.

Among the generators presently in use routinely or being investigated are tellurium-iodine; molybdenumtechnetium; strontium-yttrium; tin-indium, and so forth.

With the development of a sterile, pyrogen-free generator as set forth in U.S. Pat. No. 3,369,121, many of the systems previously utilized only experimentally have been accepted for routine use by the radiologists and the Atomic Energy CommissionQOne system at the present stage still in experimental use is the tin-indium generator. This generator is extremely useful since the half-life of Sn-l 13m is approximately 1 18 days, whereas the half-life of its daughter indium In-l 13111 is merely 1.73 hours. Thus the system can be set up to provide the practicing physician with available indium- 1 13m for scanning organisms for a period of from about 6 to 9 months. However, as it will be repeatedly utilized over this period of time, it is necessary to maintain sterility and nonpyrogenicity within the unit. One of the most vulnerable areas of possible contamination is the site of delivery. The discovery of a sterile, sealed disposable closure substantially reduces the likelihood of contamination to the system and allows the unit to be operational for long periods of time. Prior to this it was considered that the entire system was to be kept constantly sealed at all points.

DESCRIPTION OF INVENTION In order to reasonably assure the sterility and nonpyrogcnicity of a tin-indium ll3m generator, it has been discovered a disposable, sealed, sterile closure comprising a housing having a configuration wherein one end is closed by a pierceable merribrane and the opposite end remains open, a membrane filter placed between said membrane and said open end, and a seal around said closed end of the housing to retain said membrane in position will limit the hazards of contamination over the long period of time such a system is in operation. I i

The invention can be more fully understood by referring to the drawings, wherein:

FIG. 1 is a schematic view of a generator systemhaving a sterile, sealed disposable closure therein; and

FIG. 2 is a sectional view of the parts of a disposable sealed, sterile closure;

Referring to FIG. 1 eluting solution 10 is within elution bottle 12 or any other container, e.g., plastic bag. The elution bottle 12 is contacted in tandem with generator system 4 by hypodermic needle 16. This allows for eluting solution 10 to flow into generator system 4. Lead shielding 8 to prevent radioactive emission from the system encloses generator system 4. The details of generator system 4 are more fully set out in U.S. Pat. No. 3,369,121. The eluate of this system having the daughter isotope therein is removed via hypodermic needle 18 from the bottom of the generator system 4 and allowed to pass into an evacuated vial 20 through conduits 22 and 24. At point 26 on stand 28 which supports generator system 4 and shielding 8, there is a disposable sealed, sterile closure 30 of this invention which can be penetrated by hypodermic needle 32. It is to be understood that the generator system described herein canbe modified in various ways. For example, a continuous system where in lieu of hypodermic needles l6 and 18, the eluting solution and generator may be directly connected to stopper 30 by plastic conduits or fittings at 16 and 18.

The construction of closure 30 is more clearly seen in FIG. 2, wherein delivery conduit 22 is connected to retainer 36; retainer 36 being capable of fitting into outlet 26 of stand 28 and having grooves 38 or other coupling means to receive open end 40 of'housing 42 Within housing 42 which may be of teardrop configuration is membrane filter 45 which is cushioned on gasket 46 and supported by perforated filter support 44.

Pierceable membrane 48'closes housing 42 at one end and is retained in position by seal 50. Seal 50 is an aluminum seal generally utilized in autoclaving pharmaceutical preparations by placing the seal around the pierceable membrane 48 and crimping said seal. This type of seal allows for stopper 48 to be satisfactorily autoclaved and maintained in sterile condition. When the generator is ready for use, milking needle 52 is inserted into pierceable membrane 48 and eluate from elution bottle 12 passes through generator system 14. This can be accomplished by gravity flow methods or preferably by utilizing evacuated collecting vial 20 shown in FIG.

Housing material 42 as well as the other materials of this invention may be made of plastic or metal material which withstands autoclaving, e.g., about 1 15l25 C. for from 20-30 minutes at 15 lb./sq. in. gauge. Therefore, a plastic, such as polypropylene, can be utilized. In addition, other methods of sterilizing may be utilized, such as by gas sterilization with ethylene oxide. The membrane filter 45 may be between about 0.22 and 0.45 micron when utilized for sterilizing an eluate if further assurance of sterility is desired. However, if a clear eluate solution is the only requirement, then a membrane filter having a pore size greater than about 0.50 micron can be utilized, but not toexceed 2O microns.

Pierceable membrane 48 can. be made of rubberlor any other pharmaceutically acceptable grade latex material which can be pierced. t

In operation the disposable stopper of the invention is contained within a sterile pyrogen-free wrapper. The

3 technician desiring to utilize it merely opens the wrapper and passes it into connecting outlet 26. This procedure is generally carried on at least once a week or can berepeated as often as the technician deems to doso.

We claim:

1. In combination with a stand having an aperture, a disposable closure comprising a male portion and a female portion, the female portion comprising a housing, having one end closed by a pierceable membrane and the other end open and provided with coupling means adapted to be joined to the male portion, a perforated filter support disposed in the interior of said housing, between the pierceable membrane and open end, but spaced from said open end, a filter on the support in operable relation with said membrane, said filter and support being retained in a recess in said housing, and a seal around said closed end of the housing to retain said membrane in position; and the male portion comprising a housing, said male housing comprising coupling means on opposite ends of said male housing, one end of said coupling means being adapted to be joined to a delivery conduit and the otherend being constructed and arranged to be joined tov the coupling means of said female portion, said other end of said male coupling means being constructed to fit through said aperture, thereby retaining said closure on said stand.

2. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.22 to about 0.45 micron.

3. The closure of claim 2 having a teardrop configuration.

4. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.50 to 20 microns.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2127203 *Jan 30, 1936Aug 16, 1938Albert BrandAmpule
US2191447 *Apr 21, 1937Feb 27, 1940Emery S BeardsleyContainer closure
US3386585 *Nov 9, 1965Jun 4, 1968Millipore CorpFilter holder and support
US3392726 *Aug 9, 1965Jul 16, 1968Upjohn CoCombination syringe and vial container
CA692598A *Aug 18, 1964Robert C CrisafiDisposable filtering device for sterilization
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3819055 *Sep 20, 1973Jun 25, 1974Mu Eng & Mfg IncFilter cup construction
US4021353 *Nov 20, 1975May 3, 1977Burron Medical Products, Inc.Flat profile filter
US4360435 *Nov 1, 1979Nov 23, 1982Baxter Travenol Laboratories, Inc.Process for sterilizing and transferring a solution
US4422939 *Apr 8, 1982Dec 27, 1983Texas Medical Products, Inc.Blood and perfusate filter
US4786281 *Jun 30, 1986Nov 22, 1988Farmitalia Carlo Erba S.P.A.Device for connecting one end of a liquid medicament delivery cannula to an apparatus for connecting a syringe to a vial containing the medicament
US5109160 *Oct 12, 1990Apr 28, 1992E. I. Du Pont De Nemours And CompanySterilizable radionuclide generator and method for sterilizing the same
US6582665 *Jan 25, 2001Jun 24, 2003Biomedical Polymers, Inc.Universal collection and transfer system
US6918500 *Nov 28, 2001Jul 19, 2005Jms Co., Ltd.Plug body for medical fluid container
US7051906 *Oct 9, 2001May 30, 2006Novartis AgPackage for a pharmaceutical product and method of sterilizing the package
US7163114Apr 8, 2005Jan 16, 2007Jms Co., Ltd.Plug body for medical fluid container
US7322969 *Sep 13, 2002Jan 29, 2008Nipro CorporationLiquid-medicine injection port device, and liquid-medicine container provided with the same
US8192387 *Feb 29, 2008Jun 5, 2012Nxstage Medical, Inc.Sterile and non-pyrogenic (endotoxin-free) replacement fluid or dialysate may be generated in batch form by filtration; hemofiltration, hemodiafiltration hemodialysis, , ultrafiltration, infusion, and other forms of renal replacement
US8288744May 13, 2011Oct 16, 2012Mallinckrodt LlcRadiation-shielding assemblies and methods of using the same
US8362452May 13, 2011Jan 29, 2013Mallinckrodt Inc.Radiation-shielding assemblies and methods of using the same
US8513632May 13, 2011Aug 20, 2013Mallinckrodt LlcRadiation-shielding assemblies and methods of using the same
US8545428Sep 5, 2012Oct 1, 2013Nxstage Medical, Inc.Filtration system for preparation of fluids for medical applications
US8633461May 13, 2011Jan 21, 2014Mallinckrodt LlcRadiation-shielding assemblies and methods of using the same
US8679348Apr 11, 2011Mar 25, 2014Nxstage Medical, Inc.Filtration system for preparation of fluids for medical applications
US20120196358 *May 27, 2010Aug 2, 2012Fred BurbankDevice for removing cumulus from oocytes
EP2431978A1 *Jul 26, 2006Mar 21, 2012Mallinckrodt LLCRadiation-shielding assembly
EP2492920A2 *Dec 16, 2006Aug 29, 2012DRAXIMAGE General PartnershipSystems and methods for radioisotope generation
WO1998044970A1 *Apr 8, 1998Oct 15, 1998Injectimed IncMethod and apparatus for collecting blood
Classifications
U.S. Classification210/233, 210/446, 210/451, 976/DIG.350, 604/415, 210/455, 604/406
International ClassificationG21F5/015, G21F5/00, A61L2/26
Cooperative ClassificationG21G1/0005, A61L2/26, G21F5/015
European ClassificationG21F5/015, A61L2/26